 | • レポートコード：MRC2Q12-18815 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、アレルギー＆副鼻腔緩和のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 アレルギー＆副鼻腔緩和のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アレルギー＆副鼻腔緩和の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アレルギー＆副鼻腔緩和のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのアレルギー＆副鼻腔緩和の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のアレルギー＆副鼻腔緩和の売上および2028年までの予測に焦点を当てています。 アレルギー＆副鼻腔緩和のグローバル主要企業には、Cardinal Health、GSK、Bayer、Boiron、Johnson & Johnson、Insight Pharmaceuticals、Chattem、Dr Reddy's、Epic Pharma、Aurobindo Pharma USA、B. F. Ascher & Co、Geri-Care Pharmaceuticals、Lannett、Major Pharmaceuticals、Camber Pharmaceuticals Inc、OHM Laboratories、Perrigo Pharmaceuticals、Pharmaceutical Associates、Precision Dose、Raritan Pharmaceuticals、Reliable 1 Laboratoires、Rising Pharmaceuticals、Sheffield Pharmaceuticals、Taro Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アレルギー＆副鼻腔緩和市場は、タイプとアプリケーションによって区分されます。世界のアレルギー＆副鼻腔緩和市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、スプレー、その他 【アプリケーション別セグメント】 大人、子供 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アレルギー＆副鼻腔緩和製品概要 - タイプ別市場（錠剤、スプレー、その他） - アプリケーション別市場（大人、子供） - 調査の目的 ・エグゼクティブサマリー - 世界のアレルギー＆副鼻腔緩和販売量予測2017-2028 - 世界のアレルギー＆副鼻腔緩和売上予測2017-2028 - アレルギー＆副鼻腔緩和の地域別販売量 - アレルギー＆副鼻腔緩和の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アレルギー＆副鼻腔緩和販売量 - 主要メーカー別アレルギー＆副鼻腔緩和売上 - 主要メーカー別アレルギー＆副鼻腔緩和価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、スプレー、その他） - アレルギー＆副鼻腔緩和のタイプ別販売量 - アレルギー＆副鼻腔緩和のタイプ別売上 - アレルギー＆副鼻腔緩和のタイプ別価格 ・アプリケーション別市場規模（大人、子供） - アレルギー＆副鼻腔緩和のアプリケーション別販売量 - アレルギー＆副鼻腔緩和のアプリケーション別売上 - アレルギー＆副鼻腔緩和のアプリケーション別価格 ・北米市場 - 北米のアレルギー＆副鼻腔緩和市場規模（タイプ別、アプリケーション別） - 主要国別のアレルギー＆副鼻腔緩和市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアレルギー＆副鼻腔緩和市場規模（タイプ別、アプリケーション別） - 主要国別のアレルギー＆副鼻腔緩和市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアレルギー＆副鼻腔緩和市場規模（タイプ別、アプリケーション別） - 主要国別のアレルギー＆副鼻腔緩和市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアレルギー＆副鼻腔緩和市場規模（タイプ別、アプリケーション別） - 主要国別のアレルギー＆副鼻腔緩和市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアレルギー＆副鼻腔緩和市場規模（タイプ別、アプリケーション別） - 主要国別のアレルギー＆副鼻腔緩和市場規模（トルコ、サウジアラビア） ・企業情報 Cardinal Health、GSK、Bayer、Boiron、Johnson & Johnson、Insight Pharmaceuticals、Chattem、Dr Reddy's、Epic Pharma、Aurobindo Pharma USA、B. F. Ascher & Co、Geri-Care Pharmaceuticals、Lannett、Major Pharmaceuticals、Camber Pharmaceuticals Inc、OHM Laboratories、Perrigo Pharmaceuticals、Pharmaceutical Associates、Precision Dose、Raritan Pharmaceuticals、Reliable 1 Laboratoires、Rising Pharmaceuticals、Sheffield Pharmaceuticals、Taro Pharmaceutical ・産業チェーン及び販売チャネル分析 - アレルギー＆副鼻腔緩和の産業チェーン分析 - アレルギー＆副鼻腔緩和の原材料 - アレルギー＆副鼻腔緩和の生産プロセス - アレルギー＆副鼻腔緩和の販売及びマーケティング - アレルギー＆副鼻腔緩和の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アレルギー＆副鼻腔緩和の産業動向 - アレルギー＆副鼻腔緩和のマーケットドライバー - アレルギー＆副鼻腔緩和の課題 - アレルギー＆副鼻腔緩和の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Allergy and Sinus Relief estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Allergy and Sinus Relief is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Allergy and Sinus Relief is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Allergy and Sinus Relief is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Allergy and Sinus Relief include Cardinal Health, GSK, Bayer, Boiron, Johnson & Johnson, Insight Pharmaceuticals, Chattem, Dr Reddy’s and Epic Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Allergy and Sinus Relief companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Allergy and Sinus Relief market. Further, it explains the major drivers and regional dynamics of the global Allergy and Sinus Relief market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Cardinal Health
GSK
Bayer
Boiron
Johnson & Johnson
Insight Pharmaceuticals
Chattem
Dr Reddy’s
Epic Pharma
Aurobindo Pharma USA
B. F. Ascher & Co
Geri-Care Pharmaceuticals
Lannett
Major Pharmaceuticals
Camber Pharmaceuticals Inc
OHM Laboratories
Perrigo Pharmaceuticals
Pharmaceutical Associates
Precision Dose
Raritan Pharmaceuticals
Reliable 1 Laboratoires
Rising Pharmaceuticals
Sheffield Pharmaceuticals
Taro Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Allergy and Sinus Relief Segment by Type
Tablets
Sprays
Others
Allergy and Sinus Relief Segment by Application
Adult
Children
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Allergy and Sinus Relief market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Allergy and Sinus Relief market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Allergy and Sinus Relief, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Allergy and Sinus Relief, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Allergy and Sinus Relief revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Allergy and Sinus Relief market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Allergy and Sinus Relief revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cardinal Health, GSK, Bayer, Boiron, Johnson & Johnson, Insight Pharmaceuticals, Chattem, Dr Reddy’s and Epic Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Allergy and Sinus Relief in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy and Sinus Relief companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy and Sinus Relief revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergy and Sinus Relief Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Sprays
1.2.4 Others
1.3 Market by Application
1.3.1 Global Allergy and Sinus Relief Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Allergy and Sinus Relief Market Perspective (2017-2028)
2.2 Allergy and Sinus Relief Growth Trends by Region
2.2.1 Allergy and Sinus Relief Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Allergy and Sinus Relief Historic Market Size by Region (2017-2022)
2.2.3 Allergy and Sinus Relief Forecasted Market Size by Region (2023-2028)
2.3 Allergy and Sinus Relief Market Dynamics
2.3.1 Allergy and Sinus Relief Industry Trends
2.3.2 Allergy and Sinus Relief Market Drivers
2.3.3 Allergy and Sinus Relief Market Challenges
2.3.4 Allergy and Sinus Relief Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergy and Sinus Relief Players by Revenue
3.1.1 Global Top Allergy and Sinus Relief Players by Revenue (2017-2022)
3.1.2 Global Allergy and Sinus Relief Revenue Market Share by Players (2017-2022)
3.2 Global Allergy and Sinus Relief Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergy and Sinus Relief Revenue
3.4 Global Allergy and Sinus Relief Market Concentration Ratio
3.4.1 Global Allergy and Sinus Relief Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergy and Sinus Relief Revenue in 2021
3.5 Allergy and Sinus Relief Key Players Head office and Area Served
3.6 Key Players Allergy and Sinus Relief Product Solution and Service
3.7 Date of Enter into Allergy and Sinus Relief Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergy and Sinus Relief Breakdown Data by Type
4.1 Global Allergy and Sinus Relief Historic Market Size by Type (2017-2022)
4.2 Global Allergy and Sinus Relief Forecasted Market Size by Type (2023-2028)
5 Allergy and Sinus Relief Breakdown Data by Application
5.1 Global Allergy and Sinus Relief Historic Market Size by Application (2017-2022)
5.2 Global Allergy and Sinus Relief Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Allergy and Sinus Relief Market Size (2017-2028)
6.2 North America Allergy and Sinus Relief Market Size by Type
6.2.1 North America Allergy and Sinus Relief Market Size by Type (2017-2022)
6.2.2 North America Allergy and Sinus Relief Market Size by Type (2023-2028)
6.2.3 North America Allergy and Sinus Relief Market Share by Type (2017-2028)
6.3 North America Allergy and Sinus Relief Market Size by Application
6.3.1 North America Allergy and Sinus Relief Market Size by Application (2017-2022)
6.3.2 North America Allergy and Sinus Relief Market Size by Application (2023-2028)
6.3.3 North America Allergy and Sinus Relief Market Share by Application (2017-2028)
6.4 North America Allergy and Sinus Relief Market Size by Country
6.4.1 North America Allergy and Sinus Relief Market Size by Country (2017-2022)
6.4.2 North America Allergy and Sinus Relief Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Allergy and Sinus Relief Market Size (2017-2028)
7.2 Europe Allergy and Sinus Relief Market Size by Type
7.2.1 Europe Allergy and Sinus Relief Market Size by Type (2017-2022)
7.2.2 Europe Allergy and Sinus Relief Market Size by Type (2023-2028)
7.2.3 Europe Allergy and Sinus Relief Market Share by Type (2017-2028)
7.3 Europe Allergy and Sinus Relief Market Size by Application
7.3.1 Europe Allergy and Sinus Relief Market Size by Application (2017-2022)
7.3.2 Europe Allergy and Sinus Relief Market Size by Application (2023-2028)
7.3.3 Europe Allergy and Sinus Relief Market Share by Application (2017-2028)
7.4 Europe Allergy and Sinus Relief Market Size by Country
7.4.1 Europe Allergy and Sinus Relief Market Size by Country (2017-2022)
7.4.2 Europe Allergy and Sinus Relief Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergy and Sinus Relief Market Size (2017-2028)
8.2 Asia-Pacific Allergy and Sinus Relief Market Size by Type
8.2.1 Asia-Pacific Allergy and Sinus Relief Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Allergy and Sinus Relief Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Allergy and Sinus Relief Market Share by Type (2017-2028)
8.3 Asia-Pacific Allergy and Sinus Relief Market Size by Application
8.3.1 Asia-Pacific Allergy and Sinus Relief Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Allergy and Sinus Relief Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Allergy and Sinus Relief Market Share by Application (2017-2028)
8.4 Asia-Pacific Allergy and Sinus Relief Market Size by Region
8.4.1 Asia-Pacific Allergy and Sinus Relief Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Allergy and Sinus Relief Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Allergy and Sinus Relief Market Size (2017-2028)
9.2 Latin America Allergy and Sinus Relief Market Size by Type
9.2.1 Latin America Allergy and Sinus Relief Market Size by Type (2017-2022)
9.2.2 Latin America Allergy and Sinus Relief Market Size by Type (2023-2028)
9.2.3 Latin America Allergy and Sinus Relief Market Share by Type (2017-2028)
9.3 Latin America Allergy and Sinus Relief Market Size by Application
9.3.1 Latin America Allergy and Sinus Relief Market Size by Application (2017-2022)
9.3.2 Latin America Allergy and Sinus Relief Market Size by Application (2023-2028)
9.3.3 Latin America Allergy and Sinus Relief Market Share by Application (2017-2028)
9.4 Latin America Allergy and Sinus Relief Market Size by Country
9.4.1 Latin America Allergy and Sinus Relief Market Size by Country (2017-2022)
9.4.2 Latin America Allergy and Sinus Relief Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergy and Sinus Relief Market Size (2017-2028)
10.2 Middle East & Africa Allergy and Sinus Relief Market Size by Type
10.2.1 Middle East & Africa Allergy and Sinus Relief Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Allergy and Sinus Relief Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Allergy and Sinus Relief Market Share by Type (2017-2028)
10.3 Middle East & Africa Allergy and Sinus Relief Market Size by Application
10.3.1 Middle East & Africa Allergy and Sinus Relief Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Allergy and Sinus Relief Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Allergy and Sinus Relief Market Share by Application (2017-2028)
10.4 Middle East & Africa Allergy and Sinus Relief Market Size by Country
10.4.1 Middle East & Africa Allergy and Sinus Relief Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Allergy and Sinus Relief Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Allergy and Sinus Relief Introduction
11.1.4 Cardinal Health Revenue in Allergy and Sinus Relief Business (2017-2022)
11.1.5 Cardinal Health Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Allergy and Sinus Relief Introduction
11.2.4 GSK Revenue in Allergy and Sinus Relief Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Allergy and Sinus Relief Introduction
11.3.4 Bayer Revenue in Allergy and Sinus Relief Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Boiron
11.4.1 Boiron Company Details
11.4.2 Boiron Business Overview
11.4.3 Boiron Allergy and Sinus Relief Introduction
11.4.4 Boiron Revenue in Allergy and Sinus Relief Business (2017-2022)
11.4.5 Boiron Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Allergy and Sinus Relief Introduction
11.5.4 Johnson & Johnson Revenue in Allergy and Sinus Relief Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Insight Pharmaceuticals
11.6.1 Insight Pharmaceuticals Company Details
11.6.2 Insight Pharmaceuticals Business Overview
11.6.3 Insight Pharmaceuticals Allergy and Sinus Relief Introduction
11.6.4 Insight Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.6.5 Insight Pharmaceuticals Recent Developments
11.7 Chattem
11.7.1 Chattem Company Details
11.7.2 Chattem Business Overview
11.7.3 Chattem Allergy and Sinus Relief Introduction
11.7.4 Chattem Revenue in Allergy and Sinus Relief Business (2017-2022)
11.7.5 Chattem Recent Developments
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Details
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Allergy and Sinus Relief Introduction
11.8.4 Dr Reddy’s Revenue in Allergy and Sinus Relief Business (2017-2022)
11.8.5 Dr Reddy’s Recent Developments
11.9 Epic Pharma
11.9.1 Epic Pharma Company Details
11.9.2 Epic Pharma Business Overview
11.9.3 Epic Pharma Allergy and Sinus Relief Introduction
11.9.4 Epic Pharma Revenue in Allergy and Sinus Relief Business (2017-2022)
11.9.5 Epic Pharma Recent Developments
11.10 Aurobindo Pharma USA
11.10.1 Aurobindo Pharma USA Company Details
11.10.2 Aurobindo Pharma USA Business Overview
11.10.3 Aurobindo Pharma USA Allergy and Sinus Relief Introduction
11.10.4 Aurobindo Pharma USA Revenue in Allergy and Sinus Relief Business (2017-2022)
11.10.5 Aurobindo Pharma USA Recent Developments
11.11 B. F. Ascher & Co
11.11.1 B. F. Ascher & Co Company Details
11.11.2 B. F. Ascher & Co Business Overview
11.11.3 B. F. Ascher & Co Allergy and Sinus Relief Introduction
11.11.4 B. F. Ascher & Co Revenue in Allergy and Sinus Relief Business (2017-2022)
11.11.5 B. F. Ascher & Co Recent Developments
11.12 Geri-Care Pharmaceuticals
11.12.1 Geri-Care Pharmaceuticals Company Details
11.12.2 Geri-Care Pharmaceuticals Business Overview
11.12.3 Geri-Care Pharmaceuticals Allergy and Sinus Relief Introduction
11.12.4 Geri-Care Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.12.5 Geri-Care Pharmaceuticals Recent Developments
11.13 Lannett
11.13.1 Lannett Company Details
11.13.2 Lannett Business Overview
11.13.3 Lannett Allergy and Sinus Relief Introduction
11.13.4 Lannett Revenue in Allergy and Sinus Relief Business (2017-2022)
11.13.5 Lannett Recent Developments
11.14 Major Pharmaceuticals
11.14.1 Major Pharmaceuticals Company Details
11.14.2 Major Pharmaceuticals Business Overview
11.14.3 Major Pharmaceuticals Allergy and Sinus Relief Introduction
11.14.4 Major Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.14.5 Major Pharmaceuticals Recent Developments
11.15 Camber Pharmaceuticals Inc
11.15.1 Camber Pharmaceuticals Inc Company Details
11.15.2 Camber Pharmaceuticals Inc Business Overview
11.15.3 Camber Pharmaceuticals Inc Allergy and Sinus Relief Introduction
11.15.4 Camber Pharmaceuticals Inc Revenue in Allergy and Sinus Relief Business (2017-2022)
11.15.5 Camber Pharmaceuticals Inc Recent Developments
11.16 OHM Laboratories
11.16.1 OHM Laboratories Company Details
11.16.2 OHM Laboratories Business Overview
11.16.3 OHM Laboratories Allergy and Sinus Relief Introduction
11.16.4 OHM Laboratories Revenue in Allergy and Sinus Relief Business (2017-2022)
11.16.5 OHM Laboratories Recent Developments
11.17 Perrigo Pharmaceuticals
11.17.1 Perrigo Pharmaceuticals Company Details
11.17.2 Perrigo Pharmaceuticals Business Overview
11.17.3 Perrigo Pharmaceuticals Allergy and Sinus Relief Introduction
11.17.4 Perrigo Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.17.5 Perrigo Pharmaceuticals Recent Developments
11.18 Pharmaceutical Associates
11.18.1 Pharmaceutical Associates Company Details
11.18.2 Pharmaceutical Associates Business Overview
11.18.3 Pharmaceutical Associates Allergy and Sinus Relief Introduction
11.18.4 Pharmaceutical Associates Revenue in Allergy and Sinus Relief Business (2017-2022)
11.18.5 Pharmaceutical Associates Recent Developments
11.19 Precision Dose
11.19.1 Precision Dose Company Details
11.19.2 Precision Dose Business Overview
11.19.3 Precision Dose Allergy and Sinus Relief Introduction
11.19.4 Precision Dose Revenue in Allergy and Sinus Relief Business (2017-2022)
11.19.5 Precision Dose Recent Developments
11.20 Raritan Pharmaceuticals
11.20.1 Raritan Pharmaceuticals Company Details
11.20.2 Raritan Pharmaceuticals Business Overview
11.20.3 Raritan Pharmaceuticals Allergy and Sinus Relief Introduction
11.20.4 Raritan Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.20.5 Raritan Pharmaceuticals Recent Developments
11.21 Reliable 1 Laboratoires
11.21.1 Reliable 1 Laboratoires Company Details
11.21.2 Reliable 1 Laboratoires Business Overview
11.21.3 Reliable 1 Laboratoires Allergy and Sinus Relief Introduction
11.21.4 Reliable 1 Laboratoires Revenue in Allergy and Sinus Relief Business (2017-2022)
11.21.5 Reliable 1 Laboratoires Recent Developments
11.22 Rising Pharmaceuticals
11.22.1 Rising Pharmaceuticals Company Details
11.22.2 Rising Pharmaceuticals Business Overview
11.22.3 Rising Pharmaceuticals Allergy and Sinus Relief Introduction
11.22.4 Rising Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.22.5 Rising Pharmaceuticals Recent Developments
11.23 Sheffield Pharmaceuticals
11.23.1 Sheffield Pharmaceuticals Company Details
11.23.2 Sheffield Pharmaceuticals Business Overview
11.23.3 Sheffield Pharmaceuticals Allergy and Sinus Relief Introduction
11.23.4 Sheffield Pharmaceuticals Revenue in Allergy and Sinus Relief Business (2017-2022)
11.23.5 Sheffield Pharmaceuticals Recent Developments
11.24 Taro Pharmaceutical
11.24.1 Taro Pharmaceutical Company Details
11.24.2 Taro Pharmaceutical Business Overview
11.24.3 Taro Pharmaceutical Allergy and Sinus Relief Introduction
11.24.4 Taro Pharmaceutical Revenue in Allergy and Sinus Relief Business (2017-2022)
11.24.5 Taro Pharmaceutical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer